Tamsulosin Hydrochloride
Product Images NDC 33261-839

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 33261-839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Tamsulosin HCl 0 4mg Cap For Wockhardt 1)

Chemical structure of tamsulosin hydrochloride showing its molecular components including a sulfonamide group, methoxy substituent, and ethoxy-substituted aromatic ring, plus the hydrochloride salt form.*

FDA Label Image

Figure1 (Tamsulosin HCl 0 4mg Cap For Wockhardt 2)

A line graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours) up to 36 hours, comparing fed versus fasted states. The fasted state is represented by a dashed line indicating higher plasma concentrations, especially peaking earlier, while the fed state is a solid line showing lower plasma concentrations over the time course.*

FDA Label Image

Figure 2a (Tamsulosin HCl 0 4mg Cap For Wockhardt 3)

A line graph showing mean change over a treatment duration of up to 13 weeks plus LOCF. It compares three groups: TAMSULOSIN HYDROCHLORIDE 0.8 mg, 0.4 mg, and placebo. The y-axis represents mean change, and data points for each treatment group are connected by distinct line styles to show trends over time.*

FDA Label Image

Figure 2b (Tamsulosin HCl 0 4mg Cap For Wockhardt 4)

A line graph depicting mean change over time in weeks of treatment for Tamsulosin Hydrochloride at 0.3 mg and 0.4 mg doses compared to placebo. The x-axis represents duration of treatment in weeks (0 to 13 and LOCF), and the y-axis shows mean change values ranging from 0 to -11. Distinct lines represent the 0.3 mg dose, 0.4 mg dose, and placebo groups, showing greater mean change reductions for 0.3 mg and 0.4 mg compared to placebo over time.*

FDA Label Image

Figure3a (Tamsulosin HCl 0 4mg Cap For Wockhardt 5)

A line graph showing mean change in a measured variable (mL/sec) over treatment duration in weeks for Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo groups. The x-axis represents treatment duration from baseline to 13 weeks, and the y-axis measures mean change from 0 to 3. The graph compares changes among the three groups over time with sample sizes indicated at intervals.*

FDA Label Image

Figure3b (Tamsulosin HCl 0 4mg Cap For Wockhardt 6)

A line graph showing mean change in mL/sec over treatment duration in weeks for TAMSULOSIN HYDROCHLORIDE at doses 0.8 mg, 0.4 mg, and placebo. The x-axis represents treatment duration from 0 to 13 weeks, and the y-axis shows mean change from 0.0 to 3.0 mL/sec. Three lines depict outcomes for each dose including sample sizes at time points.*

FDA Label Image

Image Label (Tamsulosin HCl 0 4mg Cap For Wockhardt 7)

Label for Tamsulosin 0.4 mg capsules by Aidarex Pharmaceuticals LLC. The label states 90 capsules per package, each containing 0.4 mg Tamsulosin Hydrochloride. Capsules are described as green and orange oblong with 'W 516' on one side. Manufactured by Wockhardt Ltd., Mumbai, India. The NDC listed is 33261-0839-90.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.